IMDX

Insight Molecular Diagnostics
$3.98
−$0.12 (−2.93%)Sep 10, 2026
0.9PoorMoatMint rating

MoatMint rates Insight Molecular Diagnostics (IMDX) 0.9 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 2.0 out of 10.

Key metrics

The numbers that frame IMDX today
Market cap
$130.24M
P/E (TTM)
-2.6
EV / FCF
-3.7
Gross margin
48.3%
EV / Sales
68.5
ROIC
-1,223.3%
Div yield
0%
52wk Low
$2.42
52wk High
$8.51

IMDX stock rating

How IMDX scores on quality, value, growth, momentum and financial health
0.9out of 10
Low overallNeutral business, expensive price
Quality2.0
Growth0.3
Momentum5.1
Value1.0
Financial Health0.3

Growth

Revenue and earnings trend for IMDX
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about IMDX
Is Insight Molecular Diagnostics a good buy?
No. Insight Molecular Diagnostics has poor quality and mixed momentum. The setup is weak overall. Growth looks poor. That could put pressure on the long-term business case. We think Insight Molecular Diagnostics is selling at a very high price.
What is the market capitalization of IMDX?
Insight Molecular Diagnostics's market capitalization is $130.24M.
What is the P/E ratio for IMDX stock?
Insight Molecular Diagnostics's current P/E ratio is -2.6.
What is the 52-week high for IMDX stock?
The 52-week high for Insight Molecular Diagnostics is $8.51. The current close of $3.98 is 53.2% below that high.
What is the 52-week low for IMDX stock?
The 52-week low for Insight Molecular Diagnostics is $2.42. The current close of $3.98 is 64.5% above that low.
Does IMDX stock pay dividends?
Insight Molecular Diagnostics does not currently show a dividend per share in the company data.